Real-world safety experience of tevagrastim/ratiograstim/biograstim and tbo- filgrastim, short-acting recombinant human granulocyte colony-stimulating factors | Request PDF
FILGRASTIM Teva 30 mio U/0.5ml ser prê 0.5 ml - Pharmafoto
In Focus: Making the case for biosimilars - MM+M - Medical Marketing and Media
Filgrastim-Teva 48 Mio E/0.8ml 5 Fertspr 0.8 ml auf Rezept kaufen | Amavita
Filgrastim -Teva®
A Look at Teva's Dominance in the Biosimilar Space
Teva receives FDA approval for filgrastim in the US
Key concepts and critical issues on epoetin and filgrastim biosimilars. A position paper from the Italian Society of Hematology, Italian Society of Experimental Hematology, and Italian Group for Bone Marrow Transplantation
GRANIX - Hematology Advisor
Stability of Hospira filgrastim following changes to thermal and photic storage conditions | PPME